Back to results
US 2016/0235680 A1Published application
Pharmaceutical compositions
AssigneeBoehringer Ingelheim International GmbH
InventorsMasanori ITO, Kenji EGUSA, Roman MESSERSCHMID, Peter SCHNEIDER
Life of this patent
Estimating the term…
Abstract
The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and/or a SGLT-2 inhibitor drug, and metformin XR, processes for the preparation thereof, and their use to treat certain diseases.
Claims27
A pharmaceutical composition comprising:
- a) an inner extended release core comprising metformin or metformin hydrochloride and one or more excipients;
- b) an optional intermediate seal coating;
- and
- c) an outer immediate release coating comprising at least one active pharmaceutical ingredient, wherein said at least one pharmaceutical ingredient is a SGLT-2 inhibitor,
- and one or more excipients.
2 more elements
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A pharmaceutical composition comprising:
- a) an inner extended release core comprising metformin hydrochloride and one or more excipients;
- b) an optional intermediate seal coating;
- and
- c) an outer immediate release coating comprising at least one active pharmaceutical ingredient, wherein said at least one active pharmaceutical ingredient is 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene,
- and one or more excipients.
2 more elements
Dependencies are inferred from the claim text.